Literature DB >> 9453124

Duration of homologous porcine reproductive and respiratory syndrome virus immunity in pregnant swine.

K M Lager1, W L Mengeling, S L Brockmeier.   

Abstract

The duration of porcine reproductive and respiratory syndrome virus (PRRSV) homologous immunity was tested in this study and found to last for at least 604 days post experimental exposure to field PRRSV. Eleven gilts (group A) received a primary exposure to field PRRSV by either an oronasal (n = 6) or an intrauterine (n = 5) route. The gilts were naturally bred at selected times (143 to 514 days) after primary virus exposure. They were oronasally exposed a second time to the same strain of virus on or about gestation day 90. Ten age-matched control sows free of PRRSV-specific antibody from the same source farm (group B) were naturally bred and were oronasally exposed to aliquots of the homologous challenge virus on or about gestation day 90. Nine of the 11 gilts in group A and all animals in group B became pregnant following one breeding cycle. The two nonpregnant gilts in group A were each naturally bred during four additional estrus cycles and neither became pregnant. They were exposed to homologous challenge virus 562 and 604 days post primary exposure, respectively. All animals were necropsied 21 days post homologous challenge. Sera and alveolar macrophages from each dam, and sera from each fetus were tested for virus. Transplacental infection was detected in 0/9 and 8/10 litters in groups A and B, respectively. Virus was detected in 0/11 and 10/10 of the alveolar macrophage samples collected in groups A and B, respectively. Serum was harvested at selected times throughout the experiment and tested for PRRSV-specific antibody by indirect immunofluorescence microscopy. All gilts in group A were seropositive for the duration of the experiment, and all animals in group B seroconverted following exposure to field PRRSV. This study shows that adult swine can produce a homologous protective immunity after PRRSV exposure that may persist for the production life of the animal.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9453124     DOI: 10.1016/s0378-1135(97)00159-4

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  12 in total

1.  Porcine reproductive and respiratory syndrome virus infection at the time of porcine circovirus type 2 vaccination has no impact on vaccine efficacy.

Authors:  A Sinha; H G Shen; S Schalk; N M Beach; Y W Huang; P G Halbur; X J Meng; T Opriessnig
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

2.  Protection against porcine reproductive and respiratory syndrome virus (PRRSV) infection through passive transfer of PRRSV-neutralizing antibodies is dose dependent.

Authors:  O J Lopez; M F Oliveira; E Alvarez Garcia; B J Kwon; A Doster; F A Osorio
Journal:  Clin Vaccine Immunol       Date:  2007-01-10

3.  Virological and immunological responses to porcine reproductive and respiratory syndrome virus in a large population of gilts.

Authors:  Laura Batista; Carlos Pijoan; Scott Dee; Michael Olin; Thomas Molitor; Han Soo Joo; Zhenguo Xiao; Michael Murtaugh
Journal:  Can J Vet Res       Date:  2004-10       Impact factor: 1.310

4.  Strain predominance following exposure of vaccinated and naive pregnant gilts to multiple strains of porcine reproductive and respiratory syndrome virus.

Authors:  Kelly M Lager; William L Mengeling; Ronald D Wesley
Journal:  Can J Vet Res       Date:  2003-05       Impact factor: 1.310

5.  Antigen-specific B-cell responses to porcine reproductive and respiratory syndrome virus infection.

Authors:  Prasad Mulupuri; Jeffrey J Zimmerman; Joseph Hermann; Craig R Johnson; Jean Paul Cano; Wanqin Yu; Scott A Dee; Michael P Murtaugh
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

6.  Quantitative analysis of porcine reproductive and respiratory syndrome (PRRS) viremia profiles from experimental infection: a statistical modelling approach.

Authors:  Zeenath U Islam; Stephen C Bishop; Nicholas J Savill; Raymond R R Rowland; Joan K Lunney; Benjamin Trible; Andrea B Doeschl-Wilson
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

7.  Development of a nanoparticle-assisted PCR assay for detection of porcine epidemic diarrhea virus.

Authors:  Wanzhe Yuan; Yanan Li; Peng Li; Qinye Song; Limin Li; Jiguo Sun
Journal:  J Virol Methods       Date:  2015-04-14       Impact factor: 2.014

8.  Cytokines and synthetic double-stranded RNA augment the T helper 1 immune response of swine to porcine reproductive and respiratory syndrome virus.

Authors:  William A Meier; Robert J Husmann; William M Schnitzlein; Fernando A Osorio; Joan K Lunney; Federico A Zuckermann
Journal:  Vet Immunol Immunopathol       Date:  2004-12-08       Impact factor: 2.046

9.  Immunisation of pigs with a major envelope protein sub-unit vaccine against porcine reproductive and respiratory syndrome virus (PRRSV) results in enhanced clinical disease following experimental challenge.

Authors:  Cinta Prieto; Francisco Javier Martínez-Lobo; Francisco Díez-Fuertes; Patricia Aguilar-Calvo; Isabel Simarro; José María Castro
Journal:  Vet J       Date:  2010-08-14       Impact factor: 2.688

Review 10.  Pathogenesis and prevention of placental and transplacental porcine reproductive and respiratory syndrome virus infection.

Authors:  Uladzimir U Karniychuk; Hans J Nauwynck
Journal:  Vet Res       Date:  2013-10-07       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.